Not applicableNot Yet RecruitingNCT07067450What this trial is testingAdjuvant Immunotherapy for Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma (ESCC) Sichuan University 98
Testing effectiveness (Phase 2)Looking for participantsNCT07290010What this trial is testingThe Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy as the First-line Treatment for Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma (ESCC) Hebei Medical University Fourth Hospital 25
Testing effectiveness (Phase 2)UnknownNCT05394415What this trial is testingChemoradiation Plus Tislelizumab for Conversion Therapy of Locally Nonresectable ESCCWho this might be right forEsophageal Squamous Cell CarcinomaTislelizumabChemoradiation Jiangsu Cancer Institute & Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07493993What this trial is testingClinical Study on the Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Nab-Paclitaxel in Neoadjuvant Therapy for Locally Advanced Resectable Esophageal Squamous Cell CarcinomaWho this might be right forESCC Tianjin Medical University Cancer Institute and Hospital 26
Not applicableUnknownNCT06478355What this trial is testingImmunotherapy Combined With Chemoradiotherapy for First-line Treatment of Esophageal Squamous Cell Carcinoma（ChinECR）Who this might be right forESCC Hebei Medical University Fourth Hospital 800
Large-scale testing (Phase 3)Not Yet RecruitingNCT06501664What this trial is testingLiposomal Irinotecan and 5-FU as Second-line Therapy for Patients With ESCCWho this might be right forEsophageal Cancer Rui-hua Xu, MD, PhD 360
Not applicableStudy completedNCT06190652What this trial is testingReal-world Experience of ICIs Plus Chemotherapy With or Without Radiotherapy for Advanced ESCC.Who this might be right forMetastatic Esophageal Squamous Cell Carcinoma Tianjin Medical University Cancer Institute and Hospital 728
Not applicableLooking for participantsNCT07627347What this trial is testingEfficacy and Safety of Anlotinib Combined With Bemocizumab for Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma(ESCC)Who this might be right forESCC Nanfang Hospital, Southern Medical University 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06746961What this trial is testingEfficacy and Safety of QL1706 Plus Lenvatinib As 2nd Line Theapy in Patients with Metastatic Esophageal Carcinoma After Disease Progression on ICIs TherapyWho this might be right forEsophageal Squamous Cell Carcinoma (ESCC) The First Affiliated Hospital of Zhengzhou University 49
Large-scale testing (Phase 3)Looking for participantsNCT04973306What this trial is testingNeoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCCWho this might be right forEsophageal Squamous Cell Carcinoma Stage IIEsophageal Squamous Cell Carcinoma Stage III Shanghai Zhongshan Hospital 176
Not applicableUnknownNCT02527057What this trial is testingDiffusion-weighted Magnetic Resonance Imaging (DW-MRI )for Early Response Assessment in Patients With Esophageal CancerWho this might be right forEsophageal Carcinoma Hunan Province Tumor Hospital 90
Large-scale testing (Phase 3)UnknownNCT03623737What this trial is testingComparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCCWho this might be right forEsophageal Squamous Cell CarcinomaChemoradiation National Taiwan University Hospital 248
Testing effectiveness (Phase 2)Looking for participantsNCT04686682What this trial is testingA First-in-Human, JAB-8263 in Adult Patients With Advanced TumorsWho this might be right forNSCLCSCLCCRPC+5 more Jacobio Pharmaceuticals Co., Ltd. 152
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05732662What this trial is testingSBRT Combined With AK104 to Treatment Relapsed or Metastatic ESCCWho this might be right forRecurrent or Metastatic Esophageal Squamous Cell Carcinoma The First People's Hospital of Changzhou 25
Testing effectiveness (Phase 2)Looking for participantsNCT07205731What this trial is testingPhase II Study Evaluating Safety and Efficacy of Tislelizumab for Elderly Patients Unfit for Chemotherapy, With Advanced Esophageal Squamous-cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma (ESCC) University Hospital, Clermont-Ferrand 95
Testing effectiveness (Phase 2)Looking for participantsNCT06912074What this trial is testingHypofractionated vs. Conventional Chemoradiotherapy After Induction Chemo-immunotherapy for Unresectable Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma (ESCC) Sun Yat-sen University 134
Not applicableNot Yet RecruitingNCT07152535What this trial is testingMulti-omics Monitoring of Dynamic Evolution in Esophageal Squamous Cell Carcinoma: PKU-ESCC-MonitorWho this might be right forEsophageal Squamous Cell Carcinoma (ESCC) Peking University Cancer Hospital & Institute 255
Testing effectiveness (Phase 2)Looking for participantsNCT07038629What this trial is testingChemoradiation Plus Iparomlimab Consolidation in Older With ESCCWho this might be right forEsophageal Cancer Tianjin Medical University Cancer Institute and Hospital 52
Testing effectiveness (Phase 2)Looking for participantsNCT06601309What this trial is testingBiomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCCWho this might be right forEsophageal Squamous Cell Carcinoma Fujian Medical University Union Hospital 90
Testing effectiveness (Phase 2)Looking for participantsNCT07484724What this trial is testingA Study Evaluating the Safety and Efficacy of JS212 Combination Therapy in Patients With Advanced Esophageal Squamous Cell CarcinomaWho this might be right forAdvanced Esophageal Squamous Cell Carcinoma Shanghai Junshi Bioscience Co., Ltd. 280